Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin
Article first published online: 24 JAN 2013
© 2012 The Author(s)
The Journal of Clinical Pharmacology
Volume 53, Issue 1, pages 75–81, January 2013
How to Cite
Kim, J. W., Yi, S., Kim, T.-E., Lim, K. S., Yoon, S. H., Cho, J.-Y., Lee, M. G., Song, I.-S., Shin, S.-G., Jang, I.-J. and Yu, K.-S. (2013), Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin. Journal of Clinical Pharma, 53: 75–81. doi: 10.1177/0091270011433328
- Issue published online: 8 FEB 2013
- Article first published online: 24 JAN 2013
- Manuscript Accepted: 14 NOV 2011
- Manuscript Received: 6 JUL 2011
Supplementary data for this article are available on the journal's website at http://www.wileyonlinelibrary.com.
|jcph0091270011433328-sup-0001-FigS1.pdf||243K||Supplementary Figure S1|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.